1. Home
  2. CRIS vs CGTX Comparison

CRIS vs CGTX Comparison

Compare CRIS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • CGTX
  • Stock Information
  • Founded
  • CRIS 2000
  • CGTX 2007
  • Country
  • CRIS United States
  • CGTX United States
  • Employees
  • CRIS N/A
  • CGTX N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRIS Health Care
  • CGTX Health Care
  • Exchange
  • CRIS Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • CRIS 32.8M
  • CGTX 30.0M
  • IPO Year
  • CRIS 2000
  • CGTX 2021
  • Fundamental
  • Price
  • CRIS $3.24
  • CGTX $0.62
  • Analyst Decision
  • CRIS Strong Buy
  • CGTX Strong Buy
  • Analyst Count
  • CRIS 3
  • CGTX 6
  • Target Price
  • CRIS $23.00
  • CGTX $8.30
  • AVG Volume (30 Days)
  • CRIS 32.8K
  • CGTX 797.7K
  • Earning Date
  • CRIS 02-25-2025
  • CGTX 03-25-2025
  • Dividend Yield
  • CRIS N/A
  • CGTX N/A
  • EPS Growth
  • CRIS N/A
  • CGTX N/A
  • EPS
  • CRIS N/A
  • CGTX N/A
  • Revenue
  • CRIS $10,259,000.00
  • CGTX N/A
  • Revenue This Year
  • CRIS N/A
  • CGTX N/A
  • Revenue Next Year
  • CRIS N/A
  • CGTX N/A
  • P/E Ratio
  • CRIS N/A
  • CGTX N/A
  • Revenue Growth
  • CRIS 0.44
  • CGTX N/A
  • 52 Week Low
  • CRIS $2.86
  • CGTX $0.34
  • 52 Week High
  • CRIS $17.49
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 46.65
  • CGTX 45.57
  • Support Level
  • CRIS $3.10
  • CGTX $0.57
  • Resistance Level
  • CRIS $3.41
  • CGTX $0.64
  • Average True Range (ATR)
  • CRIS 0.18
  • CGTX 0.05
  • MACD
  • CRIS -0.00
  • CGTX -0.01
  • Stochastic Oscillator
  • CRIS 36.54
  • CGTX 21.84

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: